\nochaptercolor{mygrey}{Abréviations}
	\section*{\textcolor{mygrey}{Institutions}}
		\begin{acronym}[CDKN2A]
			\acro       {AMU}       [AMU]       {Aix-Marseille Université}
			\acro       {Cibi}      [Cibi]      {plateforme de Bioinformatique Intégrative du \acs{CRCM}}
			\acro       {CépiDc}    [CépiDc]    {Centre d'épidémiologie sur les causes médicales de décès}
			\acro       {CNRS}      [CNRS]      {Centre National de la Recherche Scientifique}
			\acro       {CRCM}      [CRCM]      {Centre de Recherche en Cancérologie de Marseille}
			\acro       {CSI}       [CSI]       {Cancer Science Institute of Singapore}
			\acro       {ENCODE}    [ENCODE]    {Encyclopedia of \acs{DNA} elements}
			\acro       {EORTC}     [EORTC]     {European Organisation for Research and Treatment of Cancer}
			\acro       {FRM}       [FRM]       {Fondation pour la Recherche Médicale}
			\acro       {GEO}       [GEO]       {Gene Expression Omnibus}
			\acro       {HUGO}      [HUGO]      {Human Genome Organisation}
			\acro       {HGNC}      [HGNC]      {\acs{HUGO} Gene Nomenclature Committee}
			\acro       {IARC}      [IARC]      {International Agency for Research on Cancer}
			\acro       {ICGC}      [ICGC]      {International Cancer Genome Consortium}
			\acro       {INCa}      [INCa]      {Institut National du Cancer}
			\acro       {INSERM}    [INSERM]    {Institut National de la Santé et de la Recherche Médicale}
			\acro       {InVS}      [InVS]      {Institut de Veille Sanitaire}
			\acro       {IPC}       [IPC]       {Institut Paoli-Calmettes}
			\acro       {IPMC}      [IPMC]      {Institut de Pharmacologie Moléculaire et Cellulaire}
			\acro       {NCBI}      [NCBI]      {National Center for Biotechnology Information}
			\acro       {NCI}       [NCI]       {National Cancer Institute}
			\acro       {ONG}       [ONG]       {Organisation non gouvernementale}
			\acro       {OMS}       [OMS]       {Organisation Mondiale de la Santé}
			\acro       {PACA}      [PACA]      {Provence Alpes Côte d'Azur}
			\acro       {SEER}      [SEER]      {Surveillance Epidemiology and End Results Program}
			\acro       {TAGC}      [TAGC]      {technological advances for genomics and clinics}
		\end{acronym}

	\section*{\textcolor{mygrey}{Divers}}
		\begin{acronym}[CDKN2A]
			\acro       {ADN}   [ADN]   {acide désoxyribonucléique (\emph{\acs{DNA}})}
			\acro       {ARN}   [ARN]   {acide ribonucléique (\emph{\acs{RNA}})}
			\acro       {ARNm}  [ARNm]  {\acs{ARN} messager (\emph{\acs{mRNA}})}
			\acro       {ARNt}  [ARNt]  {\acs{ARN} transfert (\emph{\acs{tRNA}})}
			\acro       {ATP}   [ATP]   {adénosine triphosphate}
			\acro       {DNA}   [DNA]   {desoxyribonucleic acid}
			\acro       {DMFS}  [DMFS]  {Survie sans rechute métastatique (\emph{Distant Metastasis Free Survival})}
			\acro       {ER}    [ER]    {récepteur aux {\oe}strogènes (\emph{{\oe}strogen receptor})}
			\acroplural {ER}    [ER]    {récepteurs aux {\oe}strogènes (\emph{{\oe}strogen receptors})}
			\acro       {ER+}   [ER+]   {possédant le recepteur aux {\oe}strogènes \acs{p-ESR1}}
			\acro       {ER-}   [ER-]   {ne possédant pas le recepteur aux {\oe}strogènes \acs{p-ESR1}}
			\acro       {eQTL}  [eQTL]  {expression quantitative trait locus}
			\acroplural {eQTL}  [eQTLs] {expression quantitative trait loci}
			\acro       {GEP}   [GEP]   {profil d'expression de gènes (\emph{gene expression profile})}
			\acroplural {GEP}   [GEPs]  {profils d'expression de gènes (\emph{gene expression profiles})}
			\acro       {GWAS}  [GWAS]  {étude d'association pangénomique (\emph{genome-wide association study})}
			\acroplural {GWAS}  [GWAS]  {études d'association pangénomique (\emph{genome-wide association studies})}
			\acro       {HER2}  [HER2]  {récepteur \acs{p-ERBB2} de la famille des récepteurs \acs{p-EGFR}}
			\acro       {HER2+} [HER2+] {possédant le recepteur \acs{p-ERBB2}}
			\acro       {HER2-} [HER2-] {ne possédant pas le recepteur \acs{p-ERBB2}}
			\acro       {ITIen} [ITI]   {Interactome-Transcriptome Interaction}
			\acro       {ITIfr} [ITI]   {Intégration Transcriptome-Interactome}
			\acro       {miARN} [miARN] {micro \acs{ARN} (\emph{\ac{miRNA}})}
			\acro       {miRNA} [miRNA] {micro \acs{RNA}}
			\acro       {mRNA}  [mRNA]  {messenger \ac{RNA}}
			\acro       {NGS}   [NGS]   {Séquençage de nouvelle génération (\emph{Next Generation Sequencing})}
			\acro       {pb}    [pb]    {paires de base}
			\acro       {PPI}   [PII]   {interaction protéine-protéine (\emph{protein-protein interaction})}
			\acroplural {PPI}   [PPIs]  {interactions protéine-protéine (\emph{protein-protein interactions})}
			\acro       {PR}    [PR]    {récepteur à la progestérone (\emph{Progesteron receptor})}
			\acro       {RNA}   [RNA]   {ribonucleic acid}
			\acro       {SNP}   [SNP]   {polymorphisme nucléotidique (\emph{single-nucleotide polymorphism})}
			\acroplural {SNP}   [SNPs]  {polymorphismes nucléotidiques (\emph{single-nucleotide polymorphisms})}
			\acro       {TF}    [TF]    {facteur de transcription (\emph{transcription factor})}
			\acroplural {TF}    [TFs]   {facteurs de transcription (\emph{transcription factors)}}
			\acro       {TNM}   [TNM]   {Tumeur-Ganglion-Métastase (\emph{Tumor-Node-Metastasis})}
			\acro       {tRNA}  [tRNA]  {transfer \ac{RNA}}
			\acro       {TSG}   [TSG]   {gène suppresseur de tumeurs (\emph{tumor suppressor gene})}
			\acroplural {TSG}   [TSGs]  {gènes suppresseurs de tumeurs (\emph{tumor suppressor genes})}
		\end{acronym}

	\section*{\textcolor{mygrey}{Gènes}}
		\label{app:ac:gènes}
		\begin{acronym}[CDKN2A]
			\acro       {APC}       [\emph{APC}]    {adenomatous polyposis coli}
			\acro       {AKT1}      [\emph{AKT1}]   {v-akt murine thymoma viral oncogene homolog 1}
			\acro       {AKT2}      [\emph{AKT2}]   {v-akt murine thymoma viral oncogene homolog 2}
			\acro       {ASXL1}     [\emph{ASXL1}]  {additional sex combs like 1 (Drosophila)}
			\acro       {ARNTL}     [\emph{ARNTL}]  {aryl hydrocarbon receptor nuclear translocator-like}
			\acro       {BRCA1}     [\emph{BRCA1}]  {breast cancer 1, early onset}
			\acro       {BRCA2}     [\emph{BRCA2}]  {breast cancer 2, early onset}
			\acro       {CDH1}      [\emph{CDH1}]   {cadherin 1, type 1, E-cadherin (epithelial)}
			\acro       {CDKN1B}    [\emph{CDKN1B}] {cyclin-dependent kinase inhibitor 1B (p27, Kip1)}
			\acro       {CDKN2A}    [\emph{CDKN2A}] {cyclin-dependent kinase inhibitor 2A}
			\acro       {CLOCK}     [\emph{CLOCK}]  {clock circadian regulator}
			\acro       {E2F}       [\emph{E2F}]    {E2F gene family}
			\acro       {EGF}       [\emph{EGF}]    {epidermal growth factor}
			\acro       {EGFR}      [\emph{EGFR}]   {epidermal growth factor receptor}
			\acro       {EP300}     [\emph{EP300}]  {E1A binding protein p300}
			\acro       {ERBB2}     [\emph{ERBB2}]  {v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)}
			\acro       {ESR1}      [\emph{ESR1}]   {estrogen receptor 1}
			\acro       {ESR2}      [\emph{ESR2}]   {estrogen receptor 2 (ER beta)}
			\acro       {GPER}      [\emph{GPER}]   {G protein-coupled estrogen receptor 1}
			\acro       {HRAS}      [\emph{HRAS}]   {v-Ha-ras Harvey rat sarcoma viral oncogene homolog}
			\acro       {KRAS}      [\emph{KRAS}]   {v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog}
			\acro       {MAP3K1}    [\emph{MAP3K1}] {mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase}
			\acro       {MTNR1B}    [\emph{MTNR1B}] {melatonin receptor 1B}
			\acro       {MYC}       [\emph{MYC}]    {v-myc myelocytomatosis viral oncogene homolog (avian)}
			\acro       {NF1}       [\emph{NF1}]    {neurofibromin 1}
			\acro       {NPAS2}     [\emph{NPAS2}]  {neuronal PAS domain protein 2}
			\acro       {PGR}       [\emph{PGR}]    {progesterone receptor}
			\acro       {PTEN}      [\emph{PTEN}]   {phosphatase and tensin homolog}
			\acro       {RAS}       [\emph{RAS}]    {rat sarcoma viral oncogene homolog}
			\acro       {RB1}       [\emph{RB1}]    {retinoblastoma 1}
			\acro       {SF3B1}     [\emph{SF3B1}]  {splicing factor 3b, subunit 1, 155kDa}
			\acro       {STK11}     [\emph{STK11}]  {serine/threonine kinase 11}
			\acro       {TP53}      [\emph{TP53}]   {tumor protein p53}
			\acro       {VEGFA}     [\emph{VEGFA}]  {vascular endothelial growth factor A}
			\acro       {WT1}       [\emph{WT1}]    {Wilms tumor 1}
		\end{acronym}

	\section*{\textcolor{mygrey}{Protéines}}
		\label{app:ac:protéines}
		\begin{acronym}[CDKN2A]
			\acro       {p-EGF}     [EGF]   {Pro-epidermal growth factor}
			\acro       {p-EGFR}    [EGFR]  {Epidermal growth factor receptor}
			\acro       {p-ERBB2}   [ERBB2] {Receptor tyrosine-protein kinase erbB-2}
			\acro       {p-ESR1}    [ESR1]  {Estrogen receptor}
			\acro       {p-HRAS}    [HRAS]  {GTPase HRas}
			\acro       {p-KRAS}    [KRAS]  {GTPase KRas}
			\acro       {p-MYC}     [MYC]   {Myc proto-oncogene protein}
			\acro       {p-NPAS2}   [NPAS2] {Neuronal PAS domain-containing protein 2}
			\acro       {p-PGR}     [PGR]   {Progesterone receptor}
			\acro       {p-TP53}    [TP53]  {cellular tumor antigen p53}
			\acro       {p-VEGFA}   [VEGFA] {Vascular endothelial growth factor A}
		\end{acronym}